Radium-223 May Add Small Benefit in Bone-Metastatic Breast Cancer
Adding radium-223 to estrogen therapy to target bone metastases may provide slight gain but comes with more adverse events. The study was published as a preprint and has not yet been peer reviewed.
First Look
source https://www.medscape.com/viewarticle/985868?src=rss
First Look
source https://www.medscape.com/viewarticle/985868?src=rss
Comments
Post a Comment